April 2 () - AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant ...
The World Health Organisation (WHO) identifies Non-Communicable Diseases (NCDs) as the number one cause of death worldwide [1], disproportionately affecting people in low and middle income countries ...
AstraZeneca's ambitious $80 billion revenue goal by 2030 hinges on oncology growth and successful new drug launches, but faces patent expiries and fierce competition. While current financials and ...
--Best four day stretch since the four days ending July 17, 2020, when it rose 14.76% --Up 25.24% year-to-date; on pace for best year since 2019, when it rose 31.28% --Down 6.35% from its all-time ...
Jan 9 (Reuters) - Walmart will replace British drugmaker AstraZeneca in the Nasdaq-100 Index on January 20, the exchange operator said on Friday. The retail giant said in November it would shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results